Shengping Hou Selected Research

Behcet Syndrome (Behcet's Syndrome)

11/2016	Association of TNFSF4 Polymorphisms with Vogt-Koyanagi-Harada and Behcet's Disease in Han Chinese.
2/2016	Association between Functional MICA-TM and Behcet's Disease: A Systematic Review and Meta-analysis.
1/2016	miR-23a, miR-146a and miR-301a confer predisposition to Vogt-Koyanagi-Harada syndrome but not to Behcet's disease.
1/2016	Genetic Variation in the REL Gene Increases Risk of Behcet's Disease in a Chinese Han Population but That of PRKCQ Does Not.
8/2015	Copy number variations and gene polymorphisms of complement components in ocular Behcet's disease and Vogt-Koyanagi-Harada syndrome.
3/2015	A variant of CLEC16A gene confers protection for Vogt-Koyanagi-Harada syndrome but not for Behcet's disease in a Chinese Han population.
1/2015	Interleukin-10 gene polymorphisms are associated with Behcet's disease but not with Vogt-Koyanagi-Harada syndrome in the Chinese Han population.
2/2014	Polymorphisms in genetics of vitamin D metabolism confer susceptibility to ocular Behçet disease in a Chinese Han population.
1/2014	Association of a TNIP1 polymorphism with Vogt-Koyanagi-Harada syndrome but not with ocular Behcet's disease in Han Chinese.
12/2013	A functional variant of pre-miRNA-196a2 confers risk for Behcet's disease but not for Vogt-Koyanagi-Harada syndrome or AAU in ankylosing spondylitis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shengping Hou Research Topics

Disease

26	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 11/2019 - 01/2008
19	Uveitis 01/2022 - 01/2010
15	Behcet Syndrome (Behcet's Syndrome) 11/2016 - 07/2010
14	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 01/2008
8	Anterior Uveitis 01/2017 - 01/2013
7	Ankylosing Spondylitis 01/2017 - 01/2013
4	Inflammation (Inflammations) 01/2022 - 01/2013
3	Genetic Predisposition to Disease (Genetic Predisposition) 01/2020 - 01/2013
2	Cataract (Cataracts) 01/2019 - 01/2011
2	Necrosis 01/2018 - 01/2014
2	Retinal Vasculitis 01/2013 - 01/2013
1	Blindness (Hysterical Blindness) 01/2022
1	Neuroinflammatory Diseases 01/2022
1	Vision Disorders (Hemeralopia) 01/2022
1	Retinal Diseases 01/2022
1	Immune System Diseases (Immune Disorders) 01/2021
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Alopecia (Baldness) 01/2019
1	Tinnitus 01/2019
1	Autosomal Dominant Cataract 01/2019
1	Headache (Headaches) 01/2019
1	Iridocyclitis 06/2014
1	Hepatocellular Carcinoma (Hepatoma) 06/2013
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2013
1	Erythema Nodosum 01/2013
1	AIDS-Related Complex (ARC) 01/2011

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2013
4	Interleukin-17 (Interleukin 17)IBA 01/2018 - 07/2010
4	InterleukinsIBA 01/2015 - 10/2010
3	Retinaldehyde (Retinal)IBA 01/2022 - 01/2021
3	Messenger RNA (mRNA)IBA 01/2019 - 01/2013
3	P-2 (P 2)IBA 01/2019 - 02/2014
3	MicroRNAs (MicroRNA)IBA 01/2017 - 12/2013
3	HLA Antigens (Human Leukocyte Antigens)IBA 03/2016 - 01/2008
3	Interleukin-10 (Interleukin 10)IBA 01/2015 - 01/2014
2	CytokinesIBA 01/2021 - 01/2016
2	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 01/2020 - 09/2014
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 04/2016
2	Protein Kinase C-thetaIBA 01/2019 - 01/2016
2	LigandsIBA 01/2018 - 01/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2016 - 06/2014
2	Complement System Proteins (Complement)IBA 08/2015 - 01/2015
2	Complement C4 (Complement Component 4)IBA 01/2015 - 11/2013
2	TNF Receptor-Associated Factor 5IBA 01/2014 - 01/2013
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 05/2013 - 01/2012
2	Monocyte Chemoattractant ProteinsIBA 01/2010 - 08/2009
2	Fc Receptors (Fc Receptor)IBA 05/2009 - 01/2008
2	HLA-DR53IBA 05/2009 - 01/2008
2	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 05/2009 - 01/2008
1	NF-kappa B (NF-kB)IBA 01/2022
1	Peroxiredoxin IIIIBA 01/2022
1	Galectin 3 (LGALS3)IBA 01/2022
1	icariinIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2021
1	InflammasomesIBA 01/2021
1	6-methyladenineIBA 01/2020
1	Biological ProductsIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2020
1	Acetic Acid (Vinegar)FDA LinkGeneric 01/2020
1	Long Noncoding RNAIBA 11/2019
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2019
1	Crystallins (Crystallin)IBA 01/2019
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2018
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2018
1	Carrier Proteins (Binding Protein)IBA 04/2016
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 04/2016
1	micaIBA 02/2016
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	Complement C5 (Complement 5)IBA 07/2015
1	C-Type Lectins (C-Type Lectin)IBA 03/2015
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2015
1	AntigensIBA 12/2014
1	HLA-DRB1 Chains (HLA DRB1)IBA 09/2014
1	25-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)IBA 02/2014
1	Vitamin D FDA LinkGeneric 02/2014
1	Vitamin D3 24-HydroxylaseIBA 02/2014
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2014
1	NucleotidesIBA 12/2013
1	Macrophage Migration-Inhibitory FactorsIBA 11/2013
1	HLA-B51 AntigenIBA 09/2013
1	Endoplasmic Reticulum Chaperone BiPIBA 06/2013
1	Janus Kinase 1IBA 05/2013
1	Interleukin-22 (IL-22)IBA 01/2013
1	Rheumatoid FactorIBA 01/2013
1	betaglycan (TGFBR3)IBA 04/2012
1	Janus Kinase 2IBA 01/2012
1	OsteopontinIBA 09/2011
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2011
1	EphA1 Receptor (Eph Receptor)IBA 01/2011
1	interleukin-21 (interleukin 21)IBA 11/2010
1	Interleukin-23 (Interleukin 23)IBA 07/2010
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 08/2009
1	UbiquitinIBA 01/2008

Therapy/Procedure

3	Therapeutics 01/2021 - 01/2020
1	Transplantation 01/2018